NEW YORK (TheStreet) -- CHANGE IN RATINGS
upgraded at Kaufman from Hold to Buy. $30 price target. Industry may be an early beneficiary from a recovery in the manufacturing industry.
upgraded at Kaufman from Hold to Buy. $45 price target. Stock deserves a premium valuation, and business should benefit from an early-cycle recovery in the manufacturing industry.
downgraded at Stifel from Hold to Sell. Company has little operating leverage.
price target, estimates increased at Barclays. Price target to $62 from $58 after substantial 3Q beat. 2009 and 2010 EPS lifted to $2.00 from $1.45 and to $2.25 from $1.75, respectively. Maintain Equal Weight rating.
upgraded at Goldman from Sell to Neutral. Estimates also raised, to reflect better cost controls and higher demand for construction equipment. $64 price target.
upgraded at Morgan Joseph to Buy. $55 price target. Company reported a strong quarter and still has further upside potential.
downgraded at Morgan Stanley from Overweight to Equal-weight. Stock is already pricing in a recovery in early 2010, though the company should lag its peers.
downgraded at Goldman from Buy to Neutral. Estimates also cut, to reflect lower margins, as traffic is being driven primarily from promotions. $17 price target.
( EP) downgraded at Citigroup from Buy to Hold. $12 price target. Valuation call, as production should fall 2%.
International Flavors and Fragrances
upgraded at Barclays to Equal Weight from Underweight on improving sales growth. Price target lifted to $43 from $37. 2009 EPS estimate maintained at $2.52, 2010 boosted to $3.05 from $2.79.
price target, estimates mixed at Barclays. Price target slashed to $79 from $85 after 3Q results. 2009 EPS estimate raised to $7.60 from $7.35, 2010 lowered to $7.15 from $7.70. Maintain Equal Weight rating.
downgraded at Morgan Keegan from Outperform to Market Perform. Defense business will slow in 2010 and the F-35 program could be delayed.
upgraded at JP Morgan. Rating raised to Neutral from Underweight. Price target raised to $27.50 from $14.50. Raises 2009 EPS estimates of $2.71 from $2.35.
upgraded at FBR from Underperform to Market Perform. Earnings outlook is improving, aided by better credit trends. $70 price target.
upgraded at Kaufman from Hold to Buy. $18 price target. Company has streamlined its business and the entire industry should benefit from higher manufacturing demand.
upgraded at Keybanc from Hold to Buy. $37 price target. Recent margin gains appear to be sustainable.
initiated at Merrill/BofA with an Underperform rating and $60 price target as they are cautious about near term earnings and see continued margin risk. 2010 and 2011 EPS estimate set at $1.68 and $2.15, respectively.
STOCK COMMENTS / EPS CHANGES
estimates, target increased at Bernstein. Shares of BIDU now seen reaching $460. Estimates also raised, as the company will likely post healthy margin gains this quarter. Outperform rating.
estimates boosted at UBS through 2010. Company is seeing lower costs and a better tax rate. Neutral rating and $56 price target.
Bank of NY Mellon
numbers lowered at UBS. Estimates were cut through 2010. Company is restructuring and the core business still has room for improvement. Neutral rating and new $29 price target.
added to Top Picks list at Citigroup. $26 price target. Stock looks attractive following a recent pullback, and the current valuation gives little credit to the company's pipeline. Buy rating.
numbers reduced at Citigroup. Estimates were lowered through 2012. Company is seeing pricing pressure and has little room to cut costs. Hold rating and new $9 price target.
numbers increased at Citigroup. Shares of BTU were raised through 2011. Company is benefiting from higher met coal prices and should see better demand in Asia for its China production. Buy rating and new $53 price target.
target raised at Goldman. Shares now seen reaching $34. Margins should grow down the road, aided by a better economy and a robust generic pipeline. Buy rating.
estimates reduced at Morgan Stanley through 2011. Company is seeing slower volume growth and weak pricing. Equal-weight rating.
estimates lower at Credit Suisse. 2009 EPS estimate tweaked to $3.29 from $3.26, 2010 sunk to $3.35 from $3.65 as 3Q results not as good as they look. Maintain Neutral rating and $48 price target.
estimates, target raised at Goldman. Estimates were boosted through 2011. Company should see higher margins, following sequential sales growth. Neutral rating and new $37 price target.
estimates raised at Morgan Stanley through 2012. Checks show that the market is improving. Equal-weight rating.
( CYME) price target higher at Credit Suisse, to $41 from $38 ahead of 3Q results. 2009 and 2010 EPS estimates increased to $0.58 from $0.37 and to $2.44 from $2.12, respectively. Maintain Neutral rating.
price target, estimates increased at Barclays. Price target lifted to $32 from $30 after solid 3Q results. 2009 and 2010 EPS estimates raised to $2.00 from $1.72 and to $2.15 from $1.90, respectively. Equal Weight rating.
price target lifted at Credit Suisse to $29 from $21, look for 3Q beat. Maintain Outperform rating. 2009 EPS estimate raised to $1.37 from $1.16, 2010 introduced at $1.48.
price target cut at Barclays to $49 from $50. Maintain 2009 and 2010 EPS at $3.75 and $3.71, respectively. Reiterate Overweight rating.
estimates cut at Goldman through 2014. Operating spending remains high and prescription trends have been down for Lexapro and Namenda. Sell rating and $30 price target.
( HANS) estimates raised at Goldman through 2011. Company is seeing higher royalty revenue and cutting costs. Neutral rating and $50 price target.
( HOC) estimates raised at UBS through 2010. Checks show that US sales trends are ahead of expectations. Buy rating and $46 price target.
( HOC) price target higher at Credit Suisse, to $29 from $26 after deal to buy refinery from Sinclair Oil. 2009 and 2010 EPS estimates set at $1.41 and $2.90, respectively. Maintain Neutral rating.
( HOC) estimates, target increased at Goldman through 2013. Refinery acquisition should add to earnings. Buy rating and new $40 price target.
Illinois Tool Works
numbers raised at Goldman. Shares now seen reaching $59. Estimates also increased, to reflect better auto production. Buy rating.
estimates cut at UBS through 2011. Company is cutting costs, but business is still likely to come under pressure from IBM and HPQ. Neutral rating and $9.50 price target.
numbers raised at Goldman through 2011. Growth should continue, as the company has strong operating momentum. Neutral rating and new $29 price target.
( JOYG) price target boosted at Barclays to $60 from $43. 2009 and 2010 EPS estimates increased to $4.20 from $4.15 and to $2.75 from $2.40, respectively. Maintain Overweight rating.
numbers boosted at Goldman. Shares of KO now seen reaching $62. Estimates also increased, as volume growth should accelerate in 2010, along with an improving economy. Buy rating.
price target boosted at Barclays to $25 from $18 as Oct 27 Analyst Day approaches. 2009 and 2010 EPS estimates lifted to $0.95 from $0.89 and to $1.38 from $1.20, respectively. Reiterate Equal Weight rating.
estimates, target lowered at Goldman. Shares of NUVA now seen reaching $49. Estimates also cut, to reflect a worse business mix. Buy rating.
price target, estimates higher at Credit Suisse. Price target boosted to $185 from $165 on unit volume growth. 2009 and 2010 EPS estimates increased to $7.65 from $7.50 and to $9.20 from $8.88, respectively. Maintain Outperform rating.
numbers raised at Goldman. Shares now seen reaching $118. Estimates also increased, to reflect higher margin assumptions. Neutral rating.
target boosted at Goldman. Shares now seen reaching $22. Multiple could expand, given the company's predictable earnings stream. Buy rating.
numbers raised at Goldman through 2012. Company is seeing higher margins. Sell rating and new $55 price target.
price target, estimates higher at Barclays. Price target to $70 from $60 after posting better than expected 3Q. 2009 and 2010 EPS estimates raised to $2.82 from $2.45 and to $3.82 from $3.77, respectively. Reiterate Overweight rating.
price target boosted at Credit Suisse to $108 from $91 to reflect long term upside. 2009 EPS estimate lifted to $11.83 from $11.80, 2010 cut to $10.00 from $10.13. Maintain Outperform rating.
price target, estimates lifted at Barclays. SHW price target set at $54, up from $50. 2009 EPS estimate increased to $3.73 from $3.57, 2010 introduced at $3.95. Maintain Underweight rating.
estimates raised at Goldman through 2010. Tight NAND supply should support prices. Buy rating and $24 price target.
estimates raised at UBS through 2010. Demand should ultimately recover. Buy rating and $21 price target.
estimates, target cut at UBS. Shares of STT now seen reaching $51. Estimates also lowered, to reflect lower securities lending. Neutral rating.
estimates boosted at Morgan Stanley through 2012. Company is seeing higher margins across the board. Equal-weight rating.
price target raised at Credit Suisse to $49, up from $43. Maintain 2009 EPS at $2.93, tweaking 2010 to $3.29 from $3.27. Neutral rating.
numbers boosted at Morgan Stanley. Shares now seen reaching $63. Estimates also raised, to reflect organic sales growth and margin potential. Overweight rating.
price target, estimates lower at Credit Suisse to $32 from $33 on PDP drag. 2009 EPS bumped up to $3.15 from $3.12, 2010 cut to $3.05 from $3.15. Maintain Outperform rating.
price target raised at Barclays to $76 from $60. 2010 EPS estimate cut to $4.50 from $4.55, maintain 2009 at $4.10. Reiterate Overweight rating.
numbers boosted at Citigroup. Shares now seen reaching $76. Estimates also raised, to reflect better margin execution. Buy rating.
target boosted at Citigroup to $25. Credit spreads are easing and the company is seeing lower costs in the Rockies. Buy rating.
price target boosted at Credit Suisse to $18 from $14. 2009 and 2010 EPS estimates set at $0.65 and $0.75, respectively. Reiterate Neutral rating.
estimates raised at Bernstein through 2010. Company is seeing better display ad revenue. Outperform rating and $21 price target.
This article was written by a staff member of TheStreet.com.